Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis

Cost-Effectiveness Analysis of Pembrolizumab for First-Line Treatment in Patients with Persistent, Recurrent, and Metastatic Cervical Cancer in the United States: Results from the Final Analysis of Trial

Cost-Effectiveness of Pembrolizumab Plus Chemotherapy, with or without Bevacizumab for the First-Line Treatment of Pd-L1-Positive Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in France

Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis (UC): evidence from a systematic literature review (SLR)

A systematic literature review (SLR) of real-world studies of advanced therapies in moderate-to-severe ulcerative colitis (UC): study, patient and clinical characteristics, and outcomes

Can We Speak to GPT to Inform Health Technology Assessments?

Unraveling Modeling Challenges in the Economic Evaluations of Gene Therapies: A Global Review

From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada

Methodological Insights on Indirect Treatment Comparisons for Ulcerative Colitis Therapies in NICE Submissions

Unleashing the Power of Social Media Listening: A Promising Tool for Patient-Focused Research
